Venture-Backed Startups
125,596 companies with verified investor relationships.
Biotalys develops protein-based biocontrol products for crop protection, giving farmers tools to prevent crop loss and extend post-harvest protection while reducing food waste. The agritech company builds a pipeline of products with novel modes of action targeting crop pests and diseases across the food value chain.
3 investors
EcoBiotaX develops a microbial ecology platform that uses AI (its ecoSat computational platform) and biological methods to discover and construct natural bacterial communities for specific biological functions. It targets applications in health, food, agriculture, and climate.
2 investors
Biotech Finances is a French-language news and analysis publication covering the biotech, pharma and medtech industries, focusing on financing, mergers and acquisitions, clinical developments and listed biotech valuations. It publishes articles, weekly briefings, a "Biotech Express" news feed and an industry events agenda.
1 investor
0 investors
0 investors
A biotechnology venture fund that provides venture capital investment, loans and financing facilities, guarantees, financial brokerage, and feasibility assessment services to biotech-sector companies and projects. It operates in Iran and supports affiliated companies and knowledge-based ventures.
1 investor
Biotechnologie.de is an information portal about the German and DACH-region biotechnology and life sciences industry, publishing company profiles, startup coverage, industry data, and opinion pieces. It focuses on the development of the biotech sector in Germany and Europe.
1 investor
Ulysse Biotech develops certified biological biostimulants based on Bacillus PGPR consortiums and greenhouse hygiene products for greenhouses and field crops. Its products support root growth, nitrogen fixation, and cleaning protocols for horticultural growers in Quebec and Canada.
1 investor
BiotechTV is a media outlet producing video shows, event coverage, and news focused on the biotech and healthcare sectors, including topics like venture funding, oncology conferences, and drug development. Its programming covers industry events, CEO interviews, science spotlights, and AI news for a biotech and life sciences audience.
1 investor
0 investors
0 investors
1 investor
African renewable power developer focused on South African wind and solar projects.
1 investor
BioThermic Process Controls develops single-use technology for high-fidelity temperature control of precision fermentations, aimed at bioproduct manufacturers. Its systems are intended to improve first-pass quality and yield while lowering production costs across multiple industries.
1 investor
Biotheryx uses its PRODEGY platform to discover and develop targeted protein degraders, including molecular glues and small-molecule degraders, aimed at treating cancers and other conditions with unmet needs. The company operates in the biotechnology and drug discovery sector, focused on next-generation targeted protein degradation.
2 investors
0 investors
Biotia develops diagnostic tests that use genomic sequencing to identify the root cause of patients' symptoms. The company focuses on patient-centered infectious disease and pathogen detection testing.
7 investors
Biotic Labs develops bio-based, biodegradable polymers made from feedstocks such as sea algae and agricultural waste as a direct replacement for conventional plastics. The company serves manufacturers seeking plastic alternatives that integrate into existing production lines while supporting circular economy principles.
3 investors
0 investors
BioticsAI develops AI-powered computer vision solutions for fetal anatomy screening and maternal ultrasound diagnostics. The company serves healthcare providers and maternal-fetal medicine specialists seeking to standardize and improve the accuracy of prenatal ultrasound assessments.
1 investor
0 investors
BioTissue develops and delivers regenerative allograft products made from birth tissue, using its CryoTek preservation technology to retain the structure and biology of natural tissue for healing applications. Following the sale of its surgical and wound care business, the company focuses on ocular innovation for eye care and ophthalmology.
1 investor
Biotitan develops nanotechnology-based surface treatments with bactericidal and virucidal properties for various environments. The company offers tailored turnkey solutions, training, and custom application services.
1 investor
Biotix develops natural, sustainable skincare ingredients derived from skin microbiome microbes, using an AI platform alongside biology experiments to identify and test ingredients for efficacy and safety. Its lead ingredient, Probix, is a microbial fermentation-derived compound intended to reinforce natural skin functions and protect against environmental irritants.
1 investor